Breaking News, Financial News

Financial Report: Sanofi 1Q

Genzyme sales up 31% in the quarter

Sanofi
 
1Q Revenues: €8.8 billion (+12%)
 
1Q Earnings: €1.1 billion (flat)
 
Comments: Pharmaceutical sales were €7.5 billion, up 2% at Constant Exchange Rates (CER). Diabetes sales were €1.8 billion, down 3% reflecting expected pricing impact on Lantus in the U.S.Vaccines sales were €697 million, down 5% due to expected delay in Southern Hemisphere influenza campaign. Genzyme sales were €821 million, up 31% mainly driven by Aubagio.Animal Health sales were up 14% driven by NexGard.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters